SUPPLEMENT REFERENCES

38. Aghokeng, A.F., et al., Evaluation of four simple/rapid assays and two fourth-generation ELISAs for the identification of HIV infection on a serum panel representing the HIV-1 group M genetic diversity in Cameroon. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2004. 37(5): p. 1632-40. 39. Aghokeng, A.F., et al., Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS ONE [Electronic Resource], 2009. 4(11): p. e7702. 40. Anzala, O., et al., Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing. East African Medical Journal, 2008. 85(10): p. 500-4. 41. Ashby, J., et al., HIV testing uptake and acceptability in an inner city polyclinic. AIDS Care, 2012. 24(7): p. 905-909. 42. Bajunirwe, F. and M. Muzoora, Barriers to the implementation of programs for the prevention of mother-to-child transmission of HIV: A cross-sectional survey in rural and urban Uganda. AIDS Research and Therapy, 2005. 2(1). 43. Bakari, J.P., et al., Rapid voluntary testing and counseling for HIV: Acceptability and feasibility in Zambian antenatal care clinics. 2000, New York Academy of Sciences. p. 64- 76. 44. Banwat, E.B., J.Y. Peter, and D.Z. Egah, Evaluation of commercial HIV test kits used in Nigeria. Nigerian Journal of Clinical Practice, 2009. 12(1): p. 11-4. 45. Bass, M.G., et al., Provider and practice characteristics associated with use of rapid HIV Testing by general internists. Journal of General Internal Medicine, 2011. 26(11): p. 1258-64. 46. Bassett, I.V., et al., Screening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Medicine, 2011. 12(1): p. 46-53. 47. Beckwith, C.G., et al., An evaluation of a routine opt-out rapid HIV testing program in a Rhode Island jail. AIDS Education & Prevention, 2011. 23(3 Suppl): p. 96-109. 48. Bienek, D.R. and D.G. Charlton, The effect of simulated field storage conditions on the accuracy of rapid user-friendly blood pathogen detection kits. Military Medicine, 2012. 177(5): p. 583-8. 49. Black, V., et al., Poor sensitivity of field rapid HIV testing: implications for mother-to- child transmission programme. BJOG: An International Journal of Obstetrics & Gynaecology, 2009. 116(13): p. 1805-8. 50. Bogart, L.M., et al., Scope of rapid HIV testing in private nonprofit urban community health settings in the United States. American Journal of Public Health, 2008. 98(4): p. 736-42. 51. Brown, J., et al., Routine HIV screening in the emergency department using the new US Centers for Disease Control and Prevention Guidelines: results from a high-prevalence area. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2007. 46(4): p. 395-401. 52. Brown, J., et al., Another look at Emergency Department HIV screening in practice: No need to revise expectations. AIDS Research and Therapy, 2010. 7(1). 53. Bruzzone, B., et al., HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays. Tropical Medicine & International Health, 2008. 13(7): p. 900-3. 54. Burgess-Cassler, A., et al., A field test for the detection of antibodies to human immunodeficiency virus types 1 and 2 in serum or plasma. Clinical & Diagnostic Laboratory Immunology, 1996. 3(4): p. 480-482. 55. Cabie, A., et al., Impact of rapid HIV testing on the return rate for routine test results in sexually transmitted infection testing centres. International Journal of STD & AIDS, 2011. 22(12): p. 757-8. 56. Cadoff, E.M., et al., Integrating rapid HIV testing in emergency care improves HIV detection. Point of Care, 2007. 6(3): p. 201-207. 57. Centers for Disease, C. and Prevention, False-positive oral fluid rapid HIV tests--New York City, 2005-2008. MMWR - Morbidity & Mortality Weekly Report, 2008. 57(24): p. 660-5. 58. Chetty, V., D. Moodley, and A. Chuturgoon, Evaluation of a 4th generation rapid HIV test for earlier and reliable detection of HIV infection in pregnancy. Journal of Clinical Virology, 2012. 54(2): p. 180-4. 59. Claassen, M., et al., Pitfalls with rapid HIV antibody testing in HIV-infected children in the Western Cape, South Africa. Journal of Clinical Virology, 2006. 37(1): p. 68-71. 60. Constantine, N.T., et al., Diagnostic challenges for rapid human immunodeficiency virus assays. Performance using HIV-1 group O, HIV-1 group M, and HIV-2 samples. Journal of Human Virology, 1997. 1(1): p. 45-51. 61. Cook, N. and B. Dattel, The role of the rapid HIV test in women with no prenatal care. Primary Care Update for Ob/Gyns, 1999. 6(6): p. 202-204. 62. Crucitti, T., et al., Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial. Clinical & Vaccine Immunology: CVI, 2011. 18(9): p. 1480-5. 63. Delaney, K.P., et al., Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS, 2006. 20(12): p. 1655-60. 64. Dickson-Gomez, J., et al., Resources and obstacles to developing and implementing a structural intervention to prevent HIV in San Salvador, El Salvador. Social Science and Medicine, 2010. 70(3): p. 351-359. 65. Ehrenkranz, P.D., et al., Availability of rapid human immunodeficiency virus testing in academic emergency departments. Academic Emergency Medicine, 2008. 15(2): p. 144- 50. 66. Eller, L.A., et al., Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank population. Journal of Clinical Microbiology, 2007. 45(10): p. 3281-3285. 67. Facente, S.N., et al., False positive rate of rapid oral fluid HIV tests increases as kits near expiration date. PLoS ONE [Electronic Resource], 2009. 4(12): p. e8217. 68. Farnham, P.G., et al., Comparing the costs of HIV screening strategies and technologies in health-care settings. Public Health Reports, 2008. 123 Suppl 3: p. 51-62. 69. Forsyth, S.F., et al., Would offering rapid point-of-care testing or non-invasive methods improve uptake of HIV testing among high-risk genitourinary medicine clinic attendees? A patient perspective. International Journal of STD & AIDS, 2008. 19(8): p. 550-2. 70. Garg, N., et al., Comparison of salivary and serum antibody detection in HIV-1 infection by ELISA and rapid methods in India. Tropical Doctor, 2006. 36(2): p. 108-9. 71. Gaur, S., et al., Disparity in hospital utilization of rapid HIV-1 testing for women in labor with undocumented HIV status. Maternal & Child Health Journal, 2010. 14(2): p. 268-73. 72. Gay, C.L., et al., Acute HIV infection among pregnant women in Malawi. Diagnostic Microbiology & Infectious Disease, 2010. 66(4): p. 356-360. 73. Gaydos, C.A., et al., Will patients "opt in" to perform their own rapid HIV test in the emergency department? Annals of Emergency Medicine, 2011. 58(1 Suppl 1): p. S74-8. 74. Giles, R.E., K.R. Perry, and J.V. Parry, Simple/rapid test devices for anti-HIV screening: do they come up to the mark? Journal of Medical Virology, 1999. 59(1): p. 104-9. 75. Gottfried, T.D., R.W. Mink, and P. Phanuphak, Calypte AWARE HIV-1/2 OMT antibody test using oral fluid: special challenges of rapid HIV testing in the developing world. Expert Review of Molecular Diagnostics, 2006. 6(2): p. 139-44. 76. Gray, R.H., et al., Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ, 2007. 335(7612): p. 188-190. 77. Guenter, D., et al., Rapid point-of-care HIV testing in community-based anonymous testing program: a valuable alternative to conventional testing. AIDS Patient Care & Stds, 2008. 22(3): p. 195-204. 78. Haddow, L.J. and A.J. Robinson, A case of a false positive result on a home HIV test kit obtained on the internet. Sexually Transmitted Infections, 2005. 81(4): p. 359. 79. Hamers, R.L., et al., Diagnostic accuracy of 2 oral fluid-based tests for HIV surveillance in Namibia. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2008. 48(1): p. 116- 8. 80. Heller, T., et al., Point-of-care HIV testing at antenatal care and maternity sites: experience in Battambang Province, Cambodia. International Journal of STD & AIDS, 2011. 22(12): p. 742-7. 81. Henning, M.P., C. Kruger, and L. Fletcher, HIV sero-positivity in recently admitted and long-term psychiatric in-patients: Prevalence and diagnostic profile. African Journal of Psychiatry (South Africa), 2012. 15(1): p. 47-53. 82. Herbert, R., et al., Nurse-delivered universal point-of-care testing for HIV in an open- access returning traveller clinic. HIV Medicine, 2012. 13(8): p. 499-504. 83. Holguin, A., Evaluation of three rapid tests for detection of antibodies to HIV-1 non-B subtypes. Journal of Virological Methods, 2004. 115(1): p. 105-7. 84. Holguin, A., et al., Performance of OraQuick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants. Journal of Clinical Virology, 2009. 45(2): p. 150-2. 85. Indrati, A.R., et al., Screening and diagnosis of HIV-infection in Indonesia: one, two or three tests? Acta Medica Indonesiana, 2009. 41 Suppl 1: p. 28-32. 86. Irwin, K., et al., Performance characteristics of a rapid HIV antibody assay in a hospital with a high prevalence of HIV infection. CDC-Bronx-Lebanon HIV Serosurvey Team. Annals of Internal Medicine, 1996. 125(6): p. 471-475. 87. Jafa, K., et al., Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS ONE [Electronic Resource], 2007. 2(1): p. e185. 88. Jain, S., et al., Seroprevalence study using oral rapid HIV testing in a large urban emergency department. Journal of Emergency Medicine, 2012. 43(5): p. e269-75. 89. Jamieson, D.J., et al., Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience. American Journal of Obstetrics & Gynecology, 2007. 197(3 Suppl): p. S72-82. 90. Jereni, B.H. and A.S. Muula, Availability of supplies and motivations for accessing voluntary HIV counseling and testing services in Blantyre, Malawi. BMC Health Services Research, 2008. 8: p. 17. 91. Joseph, H.A., et al., "The anticipation alone could kill you": past and potential clients' perspectives on HIV testing in non-health care settings. AIDS Education & Prevention, 2011. 23(6): p. 577-94. 92. Kagulire, S.C., et al., Field evaluation of five rapid diagnostic tests for screening of HIV-1 infections in rural Rakai, Uganda. International Journal of STD & AIDS, 2011. 22(6): p. 308-9. 93. Kaur, H., J. Dhanao, and A. Oberoi, Evaluation of rapid kits for detection of HIV, HBsAg and HCV infections. Indian Journal of Medical Sciences, 2000. 54(10): p. 432-4. 94. Keenan, P.A. and J.M. Keenan, Rapid hiv testing in urban outreach: a strategy for improving posttest counseling rates. AIDS Education & Prevention, 2001. 13(6): p. 541- 50. 95. Kelley, C.E., et al., Toward elimination of perinatal HIV transmission: New Jersey hospital barriers to rapid HIV testing in labor and delivery, 2005. Public Health Reports, 2011. 126(1): p. 145-52. 96. Ketema, F., et al., Assessment of the performance of a rapid, lateral flow assay for the detection of antibodies to HIV. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2001. 27(1): p. 63-70. 97. Kilembe, W., et al., Failure of A Novel, Rapid Antigen and Antibody Combination Test to Detect Antigen-Positive HIV Infection in African Adults with Early HIV Infection. PLoS ONE [Electronic Resource], 2012. 7(6): p. Article No. e37154. 98. Klarkowski, D.B., et al., The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS ONE [Electronic Resource], 2009. 4(2): p. e4351. 99. Kroc, K. and D. Howerton, Report of a survey of ASCP members concerning point-of-care rapid HIV testing and the clinical laboratory. Laboratory Medicine, 2005. 36(8): p. 468- 469. 100. Kroidl, I., et al., Low Specificity of Determine HIV1/2 RDT Using Whole Blood in South West Tanzania. PLoS ONE [Electronic Resource], 2012. 7(6): p. Article No. e39529. 101. Laforgerie, E., et al., Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion. Journal of Virological Methods, 2010. 165(1): p. 105-107. 102. Learmonth, K.M., et al., Assessing proficiency of interpretation of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring quality of testing. Journal of Clinical Microbiology, 2008. 46(5): p. 1692-7. 103. Lee, V.J., et al., User acceptability and feasibility of self-testing with HIV rapid tests. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2007. 45(4): p. 449-53. 104. Lejon, V., et al., Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness. Journal of Clinical Microbiology, 2010. 48(8): p. 2836-9. 105. Lyamuya, E.F., et al., Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. BMC Infectious Diseases, 2009. 9: p. 19. 106. MacPherson, P., et al., Feasibility and acceptability of point of care HIV testing in community outreach and GUM drop-in services in the North West of England: a programmatic evaluation. BMC Public Health, 2011. 11: p. 419. 107. Makuwa, M., et al., Reliability of rapid diagnostic tests for HIV variant infection. Journal of Virological Methods, 2002. 103(2): p. 183-90. 108. Maree, L., et al., Young age a predictor of weak reactivity in a rapid antibody test in infants infected with HIV. Journal of Medical Virology, 2010. 82(8): p. 1314-7. 109. Matemo, D., et al., Indeterminate rapid HIV-1 test results among antenatal and postnatal mothers. International Journal of STD & AIDS, 2009. 20(11): p. 790-2. 110. Mayhood, M.K., et al., Validation, performance under field conditions, and cost- effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania. Journal of Clinical Microbiology, 2008. 46(12): p. 3946-3951. 111. Merchant, R.C., et al., Emergency department patient perceptions and preferences on opt-in rapid HIV screening program components. AIDS Care, 2009. 21(4): p. 490-500. 112. Mfinanga, G.S., et al., Quality of HIV laboratory testing in Tanzania: a situation analysis. Tanzania Health Research Bulletin, 2007. 9(1): p. 44-7. 113. Millett, G.A., et al., Mistaken assumptions and missed opportunities: Correlates of undiagnosed HIV infection among black and Latino men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 2011. 58(1): p. 64-71. 114. Moodley, D., et al., Reliability of HIV rapid tests is user dependent. South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde, 2008. 98(9): p. 707-9. 115. Myers, J.J., et al., Routine rapid HIV screening in six community health centers serving populations at risk.[Erratum appears in J Gen Intern Med. 2010 Mar;25(3):277]. Journal of General Internal Medicine, 2009. 24(12): p. 1269-74. 116. Nogueira, S.A., et al., Assessment of a rapid HIV test strategy during labor: a pilot study from Rio de Janeiro, Brazil. Journal of Human Virology, 2001. 4(5): p. 278-82. 117. O'Connell, R.J., et al., Sensitivity of the multispot HIV-1/HIV-2 rapid test using samples from human immunodeficiency virus type 1-positive individuals with various levels of exposure to highly active antiretroviral therapy. Journal of Clinical Microbiology, 2006. 44(5): p. 1831-1833. 118. Oswalt, S., et al., Need for HIV home testing kit option and education. Journal of College Student Development, 1998. 39(6): p. 627-629. 119. Pavie, J., et al., Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS ONE [Electronic Resource], 2010. 5(7): p. e11581. 120. Phillips, S., et al., Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests. Clinical & Diagnostic Laboratory Immunology, 2000. 7(4): p. 698-9. 121. Pinkerton, S.D., et al., Cost of rapid HIV testing at 45 U.S. hospitals. AIDS Patient Care & Stds, 2010. 24(7): p. 409-13. 122. Plourde, P.J., et al., Accuracy and costs of rapid human immunodeficiency virus testing technologies in rural hospitals in Zambia. Sexually Transmitted Diseases, 1998. 25(5): p. 254-259. 123. Ray, C.S., et al., An evaluation of dipstick-dot immunoassay in the detection of antibodies to HIV-1 and 2 in Zimbabwe. Tropical Medicine & International Health, 1997. 2(1): p. 83-8. 124. Rexroth, K., K. Hare, and V.L. Kan, Rapid oral HIV screening: expectations revisited. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2011. 56(2): p. e59-60. 125. Ruutel, K., V. Ustina, and R.D. Parker, Piloting HIV rapid testing in community-based settings in Estonia. Scandinavian Journal of Public Health, 2012. 40(7): p. 629-33. 126. Samdal, H.H., et al., Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion. Clinical & Diagnostic Virology, 1996. 7(1): p. 55-61. 127. Santos, A., et al., Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic. Diagnostic Microbiology & Infectious Disease, 2011. 71(1): p. 90-2. 128. Sherman, G.G., G.A. Driver, and A.H. Coovadia, Evaluation of seven rapid HIV tests to detect HIV-exposure and seroreversion during infancy. Journal of Clinical Virology, 2008. 43(3): p. 313-6. 129. Sherman, G.G., R.R. Lilian, and A.H. Coovadia, Oral fluid tests for screening of human immunodeficiency virus-exposed infants. Pediatric Infectious Disease Journal, 2010. 29(2): p. 169-72. 130. Spielberg, F., et al., Overcoming barriers to HIV testing: Preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men. JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003. 32(3): p. 318-327. 131. Stetler, H.C., et al., Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS, 1997. 11(3): p. 369-75. 132. Sy, F.S., et al., The acceptability of oral fluid testing for HIV antibodies. A pilot study in gay bars in a predominantly rural state. Sexually Transmitted Diseases, 1998. 25(4): p. 211-5. 133. Tepper, N.K., et al., Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study. American Journal of Obstetrics & Gynecology, 2009. 201(1): p. 31.e1-6. 134. Trottier, B., et al., Sensitivity and specificity of rapid HIV testing in a community setting. Sexually Transmitted Infections, 2011. 87: p. A288. 135. van den Berk, G.E., et al., Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2. J Clin Microbiol, 2003. 41(8): p. 3868-9. 136. Watt, G., P. Chanbancherd, and A.E. Brown, Human immunodeficiency virus type 1 test results in patients with malaria and dengue infections. Clinical Infectious Diseases, 2000. 30(5): p. 819. 137. Webber, D.W. and L.O. Gostin, Discrimination based on HIV/AIDS and other health conditions: "disability" as defined under federal and state law. Journal of Health Care Law & Policy, 2000. 3(2): p. 266-329. 138. Wertheimer, S.M., Women and HIV testing in Canada: Barriers to testing as identified by service providers. Canadian Journal of Infectious Diseases and Medical Microbiology, 2011. 22: p. 97B. 139. Wesolowski, L.G., et al., Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS, 2006. 20(12): p. 1661-6. 140. Wesolowski, L.G., et al., Evaluation of Oral Fluid Enzyme Immunoassay for Confirmation of a Positive Rapid Human Immunodeficiency Virus Test Result. Clinical & Vaccine Immunology, 2009. 16(7): p. 1091-1092. 141. White, D.A.E., et al., Missed opportunities for earlier HIV diagnosis in an emergency department despite an HIV screening program. AIDS Patient Care & Stds, 2009. 23(4): p. 245-50. 142. Zachary, D., et al., Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. BMC Infectious Diseases, 2012. 12: p. 183. 143. Zaw, M., et al., Local evaluation of a rapid HIV assay for use in developing countries. Tropical Medicine and International Health, 1999. 4(3): p. 216-221. 144. Zeh, C., et al., Performance of six commercial enzyme immunoassays and two alternative HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu, Western Kenya. Journal of Virological Methods, 2011. 176(1-2): p. 24-31. 145. Zelin, J., et al., An evaluation of the performance of OraQuick(R) ADVANCE Rapid HIV- 1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK. International Journal of STD & AIDS, 2008. 19(10): p. 665-667.